
Mayo Clinic Cardiology Consultant, director of the cardio-oncology program @MayoClinic, tweets are my own
Minnesota, USA
Joined March 2016
- Tweets220
- Following150
- Followers963
- Likes507
Pinned Tweet
Finally arrived! Deepest thanks to Dr. Braunwald, all the collaborators and the entire Elsevier team! #cardiooncology @MayoClinicCV
An inspiring evening at the British Ambassador’s Residence in Washington, DC bringing together clinicians, researchers, advocates and policymakers united by a shared mission: ensuring cardiovascular health is central to every stage of cancer care.
Grateful to Sir Christian Turner and colleagues for hosting the Royal Brompton Hospital Cardio-Oncology reception, and proud to mark the forthcoming @TheLancet Group Cardio-Oncology Series ahead of #GCOS2026.
As cancer survival improves, cardiotoxicity prevention, earlier detection and lifelong cardiovascular care must no longer be an afterthought, they must be built into cancer care by design.
#CardioOncology #Cardiology #Oncology #globalhealth #healthcareinnovation
Joerg Herrmann retweeted
Fantastic session highlighting the role of AI in #cardioonc @ICOSociety
Joerg Herrmann retweeted
Thanks Dr @rc_oncneph and @ShrutiGkidney for the invitation! Outstanding meeting with great discussions ! @MayoClinicNeph @OncnephBoston26 @onconephsociety
Murine Models & Immune Therapy: What Can Mice Teach Us About AIN ?
🎙️ @HerrmannMd
How do we understand ICI-AIN when kidney biopsies give us only a snapshot?
Murine models let us track immune cells over time, dissect mechanisms and test potential therapies
@rc_oncneph
Joerg Herrmann retweeted
Can #AI predict cardiotoxicity before symptoms appear?
Join @mayocvonc and the rest of the panel at #GCOS26 to explore how #artficialintelligence is reshaping #cardiooncology care.
🎟️ Save your spot: tinyurl.com/2dx225jt
#CardioOnc #AIinHealthcare #ClinicalAI
Joerg Herrmann retweeted
Replying to @JCI_insight @VictorCuenca3
Behind the scenes from the Herrmann lab at the Mayo Clinic Rochester.
From left to right: Luis E. Gutierrez, M.D.; Victor Cuenca Narvaez, M.D. @VictorCuenca3; Michele Barbarini, M.B.B.S. @MBarbarini; Pouneh Mirkheshti; and PI Sandra M. Herrmann, M.D. @HerrmannMd.
Joerg Herrmann retweeted
Over the last decade, immune #CheckpointInhibitors have revolutionized cancer therapy. However, they can cause immune-related adverse events, including acute kidney injury.
doi.org/10.1172/jci.insight.…
Using a humanized mouse model, Victor D. Cuenca Narvaez @VictorCuenca3, Michele Barbarini @MBarbarini, and Sandra M. Herrmann @HerrmannMd & team @MayoClinic now show that TNF‑α blockade reduces kidney inflammation caused by immune checkpoint inhibitors, suggesting a potential strategy to prevent immune‑related kidney injury.
The image represents reduced TNF-α expression in the kidney tissue in the ICI-TNF-α-Blockade group (compared to ICI-Only and ICI-Cytokines).
#Nephrology
Joerg Herrmann retweeted
Immune checkpoint inhibitors (ICIs) have transformed treatment for many types of cancer. In some patients, however, ICIs are associated with immune-related complications that can affect the kidneys.
A study led by Sandra Herrmann, M.D., an onconephrologist and researcher at Mayo Clinic, helps clarify how immune-related kidney inflammation develops and provides preclinical evidence supporting a targeted approach that could improve how these side effects are managed — and could potentially be prevented.
Learn more: mayocl.in/3Omhmtk
Joerg Herrmann retweeted
TNF-α Blockade Mitigates Immune Checkpoint-Related Nephritis in a Humanized Mouse Model
@JCI_insight
@VictorCuenca3 @MayoClinicNeph
@onconephsociety
#onconephrology
First Immunocompetent chimeric 🐁 Model of ICI-AIN ! pubmed.ncbi.nlm.nih.gov/4178…
Joerg Herrmann retweeted
Absolutely thrilled to participate in this session with talks from @BlaesAnneMD @mayocvonc and Gabriele Tocchetti at #GCOS2023 @ICOSociety @HMRIAustralia @HNEHealth @heartfoundation @HeartLungCirc @Uni_Newcastle @NewcastleCardio @thecsanz @COSAoncology @cancerNSW @MedResearchNSW
Sessions underway. Whats hot this past year in #cardioonc @BlaesAnneMD @mayocvonc @SverdlovAaron #GCOS2023
Joerg Herrmann retweeted
OMG what an amazing way to start the 2nd day at #GCOS2023 !!! @mayocvonc and #DrAnaBlaes summarising the most relevant papers on cardio-onc and oncology published in 2023!! My favourite?? #STOP-CA 💊and BREXIT 🏃♀️trials
Joerg Herrmann retweeted
Sessions underway. Whats hot this past year in #cardioonc @BlaesAnneMD @mayocvonc @SverdlovAaron #GCOS2023
Joerg Herrmann retweeted
🚀📚 Exciting times in #CardioOnc! Dr. Hermann from @mayocvonc is showcasing the year's most pivotal cardio-oncology research at #GCOS2023. From childhood cancer late effects to groundbreaking clinical trials, the landscape is evolving rapidly. Dive in! 🌊
1/4
Joerg Herrmann retweeted
🎙️ Insightful conversation! @abdelcards from @mdandersonnews recently spoke with Dr. @mayocvonc of @MayoClinic. They delved into the future vision of cardio-oncology for the upcoming decade and tackled the challenges in research. Stay tuned for the highlights! 🌟
Joerg Herrmann retweeted
Register….
Join…
See you in Madrid
#cardiooncology
@dgk
@AG40_DGK @mayocvonc @matthiastotzeck @LarsMichelMD @LorenzLehmann
Joerg Herrmann retweeted
Nice to see this algorithm presented at @ERAkidney meeting @Daanvandorst @ninianlang @mayocvonc @Jorie_Vers 👇🏽 link bellow open access – at Minnesota, USA
3/ Before anticancer treatment, check:
✅ BP
✅CV risk factors, CVD history
✅ end-organ damage
✅ labs
✅ ECG& echo if cardiotoxic drugs 💔
🔗ncbi.nlm.nih.gov/pmc/article…
#ERA23
Joerg Herrmann retweeted
Great to see our paper on #cancer therapy-associated hypertension
Lloyd Butel-Simoes @TattJhong_Haw @Williams1Trent Shanathan Sritharan, Payal Gadre @HerrmannMd @mayocvonc @DoanNgo4
@ICOSociety @heartfoundation @HMRIAustralia @HNEHealth
REVIEW: Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation
ahajournals.org/doi/10.1161/…
Outstanding faculty, experts and talks at Mayo Cardio-Oncology Update 2023 @MayoClinicCV #cardio-oncology – at Scottsdale, AZ
Joerg Herrmann retweeted
Proud to share this paper on #cancer therapy-associated hypertension
Lloyd Butel-Simoes @TattJhong_Haw @Williams1Trent Shanathan Sritharan, Payal Gadre @HerrmannMd @mayocvonc @DoanNgo4
@ICOSociety @heartfoundation @HMRIAustralia @HNEHealth
ahajournals.org/doi/10.1161/…
Very happy to share our extensive review on mechanisms, clinical evidence and approaches to mitigation of #cancertreatment-associated #hypertension lnkd.in/ggShm8dE
The marked improvements in anti-cancer treatments over the last few decades, have…lnkd.in/gV25kj-U
Joerg Herrmann retweeted
Great work to @MayoClinicCV @mayocvonc @DavidHolmes2 & team on this piece on #laao in #cardioonc
(I wish this was me but this is my IC superior @yangrybadger on this :))
@DrRCChester @netta_doc @shivkumarmd @Dr_Mike_Fradley #epeeps
☂️ Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer @JACCJournals #CardioTwitter #CardioOnc #CardioEd
Joerg Herrmann retweeted
There’s still time to register for Cardio-Oncology Update 2023! @mayocvonc
Providers who care for patients with cancer, join us for Cardio-Oncology Update 2023! Our expert faculty will cover prevention, diagnosis, & management of cardiovascular diseases of patients with #cancer. April 27-29 in Arizona & via livestream: mayocl.in/412eCSZ









































